{"id":"https://openalex.org/W200263122","doi":"https://doi.org/10.1002/cncr.11745","title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early\u2010stage breast cancer","display_name":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early\u2010stage breast cancer","publication_year":2003,"publication_date":"2003-10-22","ids":{"openalex":"https://openalex.org/W200263122","doi":"https://doi.org/10.1002/cncr.11745","mag":"200263122","pmid":"https://pubmed.ncbi.nlm.nih.gov/14584060"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.11745","doi":"https://doi.org/10.1002/cncr.11745","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.11745","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group","raw_affiliation_strings":["University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I45129253"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":34.9896,"has_fulltext":false,"cited_by_count":876,"citation_normalized_percentile":{"value":0.99881587,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"98","issue":"9","first_page":"1802","last_page":"1810"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anastrozole","display_name":"anastrozole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":1.0},{"id":"https://openalex.org/keywords/adjuvant-endocrine-therapy","display_name":"adjuvant endocrine therapy","score":0.9079999923706055},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.9990000128746033},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8450000286102295},{"id":"https://openalex.org/keywords/time-to-recurrence","display_name":"time to recurrence","score":0.9670000076293945},{"id":"https://openalex.org/keywords/contralateral-breast-cancer","display_name":"contralateral breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hormone-receptor-positive-tumors","display_name":"hormone receptor-positive tumors","score":0.9509999752044678},{"id":"https://openalex.org/keywords/atac-trial","display_name":"ATAC trial","score":0.847000002861023},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.6990000009536743},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7049999833106995},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C2776215463","wikidata":"https://www.wikidata.org/wiki/Q419143","display_name":"Anastrozole","level":5,"score":0.9618321061134338},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9413718581199646},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.8830655813217163},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7462663054466248},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.668250322341919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6178421378135681},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5076512098312378},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5003063678741455},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.45946621894836426},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.41851821541786194},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41763097047805786},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3727589249610901},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077384","descriptor_name":"Anastrozole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017698","descriptor_name":"Postmenopause","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047072","descriptor_name":"Aromatase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1002/cncr.11745","doi":"https://doi.org/10.1002/cncr.11745","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.11745","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:14584060","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14584060","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:106981","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/106981/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer , 98 (9) 1802 - 1810. (2003)","raw_type":"Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:17374","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/17374/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer , 98 (9) pp. 1802-1810. (2003)","raw_type":"Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/28a456f8-d264-42be-985b-fd0cd2170bdc","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/28a456f8-d264-42be-985b-fd0cd2170bdc","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Baum, M, Buzdar, A, Cuzick, J, Forbes, J, Houghton, J, Howell, A & Sahmoud, T 2003, 'Anastrozole Alone or in Combination with Tamoxifen versus Tamoxifen Alone for Adjuvant Treatment of Postmenopausal Women with Early-Stage Breast Cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial Efficacy and Safety Update Analyses', Cancer, vol. 98, no. 9, pp. 1802-1810. https://doi.org/10.1002/cncr.11745","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W1453600927","https://openalex.org/W2018309065","https://openalex.org/W2064286144","https://openalex.org/W2258218025"],"related_works":["https://openalex.org/W7073949376","https://openalex.org/W2311518691","https://openalex.org/W1995073588","https://openalex.org/W2112780046","https://openalex.org/W2530873827","https://openalex.org/W2019203094","https://openalex.org/W55130308","https://openalex.org/W2072150780","https://openalex.org/W2129148759","https://openalex.org/W2051499006"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,155,181,260],"first":[2,61,89,114,270],"analysis":[3,90,115,263],"of":[4,38,48,59,70,79,93,116,162,268,339,374,385,403],"the":[5,54,57,60,77,88,107,113,117,248,266,269,310,329,336,360,383,393,401],"ATAC":[6,118],"(Arimidex,":[7],"Tamoxifen":[8],"Alone":[9],"or":[10],"in":[11,20,36,106,112,160,167,247,272,309,328,359,372,392],"Combination)":[12],"trial":[13],"(median":[14,91],"follow-up,":[15],"33":[16],"months)":[17],"demonstrated":[18],"that":[19,273,335,382],"adjuvant":[21],"endocrine":[22],"therapy":[23],"for":[24,134,183,190,210,286,321,400,410],"postmenopausal":[25,411],"patients":[26,135,168,191,211],"with":[27,76,139,169,195,207,212,377,413],"early-stage":[28,415],"breast":[29,50,416],"cancer,":[30],"anastrozole":[31,137,159,193,231,311,340,349,367,386,404],"was":[32,164,245],"superior":[33,353],"to":[34,43,229,324,351,389],"tamoxifen":[35,142,198,330],"terms":[37,161,373],"disease-free":[39],"survival":[40],"(DFS),":[41],"time":[42],"recurrence":[44],"(TTR),":[45],"and":[46,102,242,281,299,316,396],"incidence":[47,225],"contralateral":[49],"cancer":[51,275],"(CLBC).":[52],"In":[53],"current":[55],"article,":[56],"results":[58,78,333],"efficacy":[62],"update,":[63],"based":[64],"on":[65],"a":[66,187,406],"median":[67],"follow-up":[68,347],"period":[69],"47":[71],"months,":[72],"are":[73,387],"reported":[74],"along":[75],"an":[80,345],"updated":[81,261],"safety":[82,103,262,337],"analysis,":[83,271],"performed":[84],"7":[85],"months":[86],"after":[87],"duration":[92],"treatment,":[94],"36.9":[95],"months).":[96],"METHODS:":[97],"DFS,":[98],"TTR,":[99],"CLBC":[100,224],"incidence,":[101],"were":[104],"assessed":[105],"same":[108],"patient":[109],"group":[110],"as":[111,405],"trial.":[119],"RESULTS:":[120],"DFS":[121,163],"estimates":[122],"at":[123],"4":[124],"years":[125],"remained":[126,341],"significantly":[127],"more":[128],"favorable":[129],"(86.9%":[130],"vs.":[131],"84.5%,":[132],"respectively)":[133],"receiving":[136,141,192,197],"compared":[138,194,376],"those":[140,196],"(hazard":[143],"ratio":[144,233],"[HR],":[145],"0.86;":[146],"95%":[147,175,201,218,236,254],"confidence":[148],"interval":[149],"[CI],":[150],"0.76-0.99;":[151],"P":[152,178,204,221,239,257],"=":[153,179,205,222,240,258,277],"0.03).":[154],"benefit":[156,189,209],"generated":[157],"by":[158],"even":[165],"greater":[166],"hormone":[170,213,249,363],"receptor-positive":[171,214,250,364],"tumors":[172,215],"(HR,":[173,199,216],"0.82;":[174],"CI,":[176,202,219,237,255],"0.70-0.96;":[177],"0.014).":[180],"HR":[182],"TTR":[184],"also":[185,227,264],"indicated":[186,334],"significant":[188],"0.83;":[200],"0.71-0.96;":[203],"0.015),":[206],"additional":[208,346],"0.78;":[217],"0.65-0.93;":[220],"0.007).":[223],"data":[226],"continued":[228,323],"favor":[230],"(odds":[232],"[OR],":[234],"0.62;":[235],"0.38-1.02;":[238],"0.062),":[241],"statistical":[243],"significance":[244],"achieved":[246],"subgroup":[251],"(OR,":[252],"0.56;":[253],"0.32-0.98;":[256],"0.042).":[259],"confirmed":[265],"findings":[267,380],"endometrial":[274],"(P":[276,283,290,296,302,318],"0.007),":[278],"vaginal":[279],"bleeding":[280],"discharge":[282],"<":[284,291,297,303,319],"0.001":[285,320],"both),":[287],"cerebrovascular":[288],"events":[289,295],"0.001),":[292,298],"venous":[293],"thromboembolic":[294],"hot":[300],"flashes":[301],"0.001)":[304],"all":[305],"occurred":[306],"less":[307,326],"frequently":[308,327],"group,":[312],"whereas":[313],"musculoskeletal":[314],"disorders":[315],"fractures":[317],"both)":[322],"occur":[325],"group.":[331],"These":[332,379],"profile":[338],"consistent.":[342],"CONCLUSIONS:":[343],"After":[344],"period,":[348],"continues":[350],"show":[352],"efficacy,":[354],"which":[355],"is":[356],"most":[357],"apparent":[358],"clinically":[361],"relevant":[362],"population.":[365],"Furthermore,":[366],"has":[368],"numerous":[369],"noteworthy":[370],"advantages":[371],"tolerability":[375],"tamoxifen.":[378],"suggest":[381],"benefits":[384],"likely":[388],"be":[390],"maintained":[391],"long":[394],"term":[395],"provide":[397],"further":[398],"support":[399],"status":[402],"valid":[407],"treatment":[408],"option":[409],"women":[412],"hormone-sensitive":[414],"cancer.":[417]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":22},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":18},{"year":2015,"cited_by_count":25},{"year":2014,"cited_by_count":19},{"year":2013,"cited_by_count":40},{"year":2012,"cited_by_count":27}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}